×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Shalby Limited | 2421.77 | 256.95 | 2366.54 | 2.39 | 2,531 | 32.1 |
| NOVARTIS INDIA LTD. | NA | NA | NA | NA | 2283 | 22.2 |
| AMRUTANJAN HEALTH CARE LTD. | 984.73 | 83.11 | 940.46 | 2.87 | 2208 | 108.0 |
Shalby Limited, with Security Code 540797, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 211.1 | 217.1 | 195.2 | 206.3 | 232.7 | 232.7 | 212.3 | 220.6 | 207.1 | 236.7 |
| Expenses | 166.6 | 165.6 | 151.9 | 168.1 | 182.2 | 182.2 | 176.8 | 178.1 | 176.2 | 189.8 |
| Operating Profit | 44.5 | 51.5 | 43.2 | 38.3 | 50.5 | 50.5 | 35.5 | 42.5 | 30.8 | 46.8 |
| OPM % | 21.07% | 23.74% | 22.14% | 18.54% | 21.71% | 21.71% | 16.71% | 19.27% | 14.9% | 19.79% |
| Other Income | 5.3 | 6.0 | 5.2 | 4.4 | 7.5 | 7.5 | 5.3 | 6.3 | 7.1 | 5.5 |
| Interest | 0.6 | 0.7 | 0.6 | 1.0 | 2.7 | 2.7 | 2.7 | 3.1 | 2.7 | 2.6 |
| Depreciation | 9.2 | 9.4 | 9.3 | 9.1 | 9.5 | 9.5 | 9.8 | 9.9 | 9.6 | 9.7 |
| Profit before tax | 40.0 | 47.3 | 38.5 | 32.5 | 45.8 | 45.8 | 28.3 | 35.8 | 25.7 | 40.1 |
| Tax % | -34.6% | -35.8% | -35.7% | -30.6% | 33.5% | -33.5% | -38.7% | 41.7% | -41.7% | 35.9% |
| Net Profit | 26.2 | 30.4 | 24.7 | 22.6 | 30.5 | 30.5 | 17.3 | 20.9 | 15.0 | 25.7 |
| EPS in Rs | 2.44 | 2.83 | 2.3 | 2.1 | 2.84 | 2.84 | 1.61 | 1.94 | 0 | 2.39 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 199.0 | 235.5 | 238.0 | 216.0 | 244.2 | 278.9 | 278.9 | 267.5 | 275.6 | 264.9 |
| Expenses | 173.3 | 192.4 | 185.3 | 173.7 | 205.4 | 233.7 | 233.7 | 234.9 | 241.7 | 244.0 |
| Operating Profit | 25.7 | 43.1 | 52.7 | 42.3 | 38.9 | 45.2 | 45.2 | 32.6 | 33.9 | 20.9 |
| OPM % | 12.89% | 18.32% | 22.15% | 19.59% | 15.91% | 16.21% | 16.21% | 12.2% | 12.3% | 7.89% |
| Other Income | 9.2 | 4.5 | 5.4 | 4.5 | 5.0 | 9.7 | 9.7 | 7.2 | 5.4 | 5.3 |
| Interest | 2.8 | 2.8 | 3.2 | 3.6 | 6.5 | 8.1 | 8.1 | 9.3 | 10.7 | 10.7 |
| Depreciation | 12.8 | 11.9 | 12.3 | 12.4 | 15.6 | 16.4 | 16.4 | 16.8 | 16.3 | 16.2 |
| Profit before tax | 19.2 | 33.0 | 42.6 | 30.8 | 21.8 | 30.4 | 30.4 | 13.7 | 12.4 | -0.7 |
| Tax % | -27.6% | -36.9% | -35.3% | -38.1% | -26.4% | -51.5% | 51.5% | 82.8% | -124.2% | 0% |
| Net Profit | 13.9 | 20.8 | 27.6 | 19.1 | 16.0 | 14.7 | 14.7 | 2.4 | -3.0 | -12.2 |
| EPS in Rs | 1.29 | 1.94 | 2.57 | 1.78 | 1.49 | 1.37 | 1.37 | 0.22 | -0.28 | -1.13 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 26% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 25% |
| 3 Years: | 32% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 27% |
| 3 Years: | 23% |
| 1 Year: | -26% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 15% |
| 3 Years: | 29% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 20% |
| 3 Years: | 22% |
| TTM: | -61% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 27% |
| 3 Years: | 23% |
| 1 Year: | -26% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|